Simpson Reps Daiichi Sankyo In $805M Plexxikon Buy
Daiichi Sankyo Co. Ltd. said Tuesday it will pay $805 million to buy Plexxikon Inc., a privately held pharmaceutical company based in Berkeley, Calif., with a promising late-stage treatment for metastatic...To view the full article, register now.
Already a subscriber? Click here to view full article